Shoulder Innovations Inc

Shoulder Innovations Inc (SI) Stock Analysis

$19.660

-0.090 (-0.46%)At close

Loading chart…
High
19.810
Open
19.500
VWAP
19.60
Volume
67.34K
Mkt Cap
—
Low
19.335
Amount
1.32M
EV/EBITDA, TTM
0.00

Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on transforming the shoulder surgical care market. The Company offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design.

AI analysis of Shoulder Innovations Inc (SI)

Buy

Shoulder Innovations Inc is a good buy right now due to its recent strong revenue growth, with Q2 2026 revenue reported at $17.2 million, exceeding expectations. The company has a gross margin of 78.3%, indicating effective cost management. Additionally, analysts have raised their price targets, with UBS targeting $28, suggesting significant upside potential from the current price of $18.09. However, the main risk is the negative net income reported for Q2 2026 at -$10.15 million, which investors should monitor closely.

Valuation Metrics

The current forward P/E ratio for Shoulder Innovations Inc (SI) is 0.00, compared to its 5-year average forward P/E of -9.14.

Forward P/E

Strongly Overvalued
5Y Average P/E
-9.14
Current P/E
0.00
Overvalued
-7.51
Undervalued
-10.76

Forward EV/EBITDA

Strongly Overvalued
5Y Average EV/EBITDA
-12.14
Current EV/EBITDA
0.00
Overvalued
-8.35
Undervalued
-15.93

Forward P/S

Fair
5Y Average P/S
4.72
Current P/S
4.55
Overvalued
5.67
Undervalued
3.77

Events Timeline

2026-09-10 (ET)

16:30:00

Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head

2026-09-09 (ET)

16:30:00

Shoulder Innovations Enters Exclusive Collaboration with ALM Ortho

2026-09-08 (ET)

16:30:00

Shoulder Innovations Settles Patent Litigation with Catalyst OrthoScience

2026-08-10 (ET)

07:30:00

Shoulder Innovations Appoints Jon Osborne as Chief Commercial Officer

2026-08-07 (ET)

16:30:00

Shoulder Innovations Files $300M Mixed Securities Shelf

News

SI FAQ — answered by Alphio AI

Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on transforming the shoulder surgical care market. The Company offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design. It operates in the Healthcare sector.

Shoulder Innovations Inc is a good buy right now due to its recent strong revenue growth, with Q2 2026 revenue reported at $17.2 million, exceeding expectations. The company has a gross margin of 78.3%, indicating effective cost management. Additionally, analysts have raised their price targets, with UBS targeting $28, suggesting significant upside potential from the current price of $18.09. However, the main risk is the negative net income reported for Q2 2026 at -$10.15 million, which investors should monitor closely.

Community

More ↗

**$SI /USDT Perpetual Contract – "Continued Downtrend – Short"** Short trade plan for $SI Entry price: 0.01400 Stop loss: 0.01423 Take profit 1: 0.01296 Take profit 2: 0.01249 SI is down -13.36% and has been in a downtrend since the 0.01580 high. MACD is negative; target is the 0.01265 low.

Show more
dump_spindle6 days ago

If you hold $FTR tokens, check whether you've received dividends in $TSLAx and $SPCX. Look right away. If you haven't received them (and even if you have, check carefully, because you may also be missing dividends from other tokens), read this article to the end. It could save you a significant loss over time, possibly hundreds of U, even thousands or tens of thousands of U. #FTR was launched through the $OTC platform. Trading fees are distributed as dividends in TSLAx and Musk's SPCX. But my FOMO account only received SPCX, not TSLAx. I looked into why, and that's how I found out. Read carefully, because I missed dividends too, including on $SI, which I bought earlier. It was also launched on the OTC platform and distributes dividends in six tokens, and I missed a lot of those dividends as well. If you hold $FTR or $SI (or any other token with dividend features) and want to receive dividends, first your SOL wallet address needs to have the ATA account for that token opened. In plain terms: do you remember the SOL account rent reclaim feature? That's the one that closes the ATA account and returns your SOL rent. Every token corresponds to an ATA account. For tokens launched on the OTC platform, if the ATA account for a dividend token isn't opened, the dividend is simply forfeited and won't be paid to you later. That's a huge loss. How do you solve this? Remember, this isn't only about the OTC launch platform. Any token with dividends requires attention to this issue. Some dividend token launch platforms will automatically open the ATA account for you, but you can't be sure all dividends will be opened automatically. If you don't pay attention, you'll lose a lot of dividends for nothing. Over time, this can add up to the hundreds of U, thousands of U, or even tens of thousands of U I mentioned at the start. 1. Don't claim SOL rent reclaim unless you're done using that SOL wallet address. Otherwise, don't close ATA accounts to claim that SOL. That SOL stays there forever. When you stop using the SOL wallet address, you can claim it all at once anytime. Don't proactively close accounts when there's no need. 2. When you come across a token, first send its CA to GROK and ask whether the token pays dividends, then ask exactly which tokens are paid as dividends. If you've never actively traded the dividend token, spend a small amount (any amount) to buy some. That way, your SOL wallet address opens the ATA account for that dividend token, and you can receive dividends smoothly. Remember, any amount, even 0.0001U, works. 3. You can use another wallet to transfer to the wallet that needs the ATA account opened. For example, if wallet A buys token P, and token P pays dividends in token C, you can first use wallet B to buy a small amount of dividend token C, then transfer token C from wallet B to your wallet A. Wallet A will also open the corresponding ATA account for token C and can receive dividends smoothly. For point 3, some launch platforms will proactively open the ATA account for you, but with platforms like OTC, your dividends are simply gone. So when you're not sure, it's best to proactively open the ATA account for the dividend token to reduce unnecessary losses. Use FOMO for scanning chains. Full-chain trading requires no reserved GAS and no cross-chain bridging:

Show more
WickScout10/15/2026

AI narrative is all about expectation gaps! 🧠⚡️ $SI Super Intelligence, BNB Chain AI Meme is worth a look. Whether it can break out ultimately depends on capital and price-volume action. #SI #BNB #AI #Meme #DOGE #PEPE

Show more
CobaltRunner10/14/2026

$SI just had a sharp move, up 21.96% in one hour, pushing its market cap past $50 million. For a project of this size, that kind of slope suggests it is not just scattered funds testing the waters, but a consensus forming quickly in a short period. On-chain projects like this often come and go fast, so the key is to watch position changes and contract funding rates over the next 24 hours. If the funding rate turns positive and open interest does not drop, it means longs have not scattered yet. But my usual approach is: do not chase highs, do not guess tops. The liquidity premium on small-cap tokens can backfire at any time, especially with a one-hour pulse like this. If you are genuinely interested, first dig into the project fundamentals, figure out whether it is narrative-driven or has real product iteration, and then decide whether to sit at the table.

Show more
Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading